Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.47 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.41 |
| ▸ | TSHR | P16473 | 5/20 | 0.40 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.40 |
| ▸ | LMNA | P02545 | 2/20 | 0.40 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.40 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.40 |
| ▸ | CA12 | O43570 | 1/20 | 0.39 |
| ▸ | CA1 | P00915 | 1/20 | 0.39 |
| ▸ | CA2 | P00918 | 1/20 | 0.39 |
| ▸ | CA9 | Q16790 | 1/20 | 0.39 |
| ▸ | MAOA | P21397 | 1/20 | 0.39 |
| ▸ | MAOB | P27338 | 1/20 | 0.39 |
| ▸ | GPR84 | Q9NQS5 | 7/20 | 0.38 |
| ▸ | PPARG | P37231 | 6/20 | 0.38 |
| ▸ | PPARD | Q03181 | 6/20 | 0.38 |
| ▸ | PPARA | Q07869 | 6/20 | 0.38 |
| ▸ | HDAC11 | Q96DB2 | 5/20 | 0.38 |
| ▸ | TLR2 | O60603 | 2/20 | 0.38 |
| ▸ | MEN1 | O00255 | 2/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL992117 | 1.00 | ALDH1A1 (0.47) | ALDH1A1EPHX2TSHRTDP1LMNA | |
| SCHEMBL3486013 | 1.00 | ALDH1A1 (0.47) | ALDH1A1EPHX2TSHRTDP1LMNA | |
| SCHEMBL7519278 | 0.88 | PAOX (0.42) | TDP1CA12CA1CA2CA9 | |
| SCHEMBL8374138 | 0.86 | MEN1 (0.39) | TDP1LMNACA12CA1CA2 | |
| SCHEMBL3485693 | 0.85 | TSHR (0.44) | ALDH1A1TSHRTDP1LMNACA12 | |
| SCHEMBL3486237 | 0.84 | TDP1 (0.43) | EPHX2TSHRTDP1LMNACA12 | |
| SCHEMBL15341460 | 0.83 | EPHX1 (0.46) | TDP1CA12CA1CA2CA9 | |
| SCHEMBL7527615 | 0.83 | EPHX1 (0.46) | TDP1CA12CA1CA2CA9 | |
| SCHEMBL5493650 | 0.83 | TDP1 (0.59) | TDP1CA12CA1CA2CA9 | |
| SCHEMBL5498803 | 0.83 | TDP1 (0.42) | TDP1CA12CA1CA2CA9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250108048-A1 | STING AGONIST COMPOUNDS AND CONJUGATES | SUTRO BIOPHARMA, INC. | 2025-04-03 | — | — | US | disclosed |
| WO-2025029832-A2 | STING AGONIST COMPOUNDS AND CONJUGATES | SUTRO BIOPHARMA, INC. (US) | 2025-02-06 | — | — | WO | disclosed |
| CN-114466869-B | Hydrogel composition and use thereof | 莫莉·桑德拉·萧伊凯特 | 2024-03-19 | — | — | CN | disclosed |
| US-20230133656-A1 | HYDROGEL COMPOSITIONS AND USES THEREOF | SHOICHET, MOLLY SANDRA (CA) | 2023-05-04 | — | — | US | disclosed |
| US-20230133656-A1 | HYDROGEL COMPOSITIONS AND USES THEREOF | SHOICHET, MOLLY SANDRA (CA) | 2023-05-04 | — | — | US | disclosed |
| EP-3994183-A1 | HYDROGEL COMPOSITIONS AND USES THEREOF | Shoichet, Molly Sandra (CA) | 2022-05-11 | — | — | EP | disclosed |
| CN-114466869-A | Hydrogel composition and use thereof | 莫莉·桑德拉·萧伊凯特 | 2022-05-10 | — | — | CN | disclosed |
| WO-2021000050-A1 | HYDROGEL COMPOSITIONS AND USES THEREOF | SHOICHET MOLLY SANDRA (CA) | 2021-01-07 | — | — | WO | disclosed |
| US-20070191263-A1 | Valency platform molecules comprising aminooxy groups | LA JOLLA PHARMACEUTICAL COMPANY (US) | 2007-08-16 | — | — | US | disclosed |
| US-20060141597-A1 | A conjugate of biologically active molecules e.g peptides, proteins, nucleic acids, hormones, lipids, antibodies, saccharides, epitopes, enzymes, drugs etc. and a polyoxyethylene containing aminoxy groups | JONES DAVID S | 2006-06-29 | — | — | US | disclosed |
| US-20040224366-A1 | Valency platform molecules comprising aminooxy groups | JONES DAVID S (US) | 2004-11-11 | — | — | US | disclosed |
| EP-1183230-A1 | VALENCY PLATFORM MOLECULES COMPRISING AMINOOXY GROUPS | LA JOLLA PHARMACEUTICAL (US) | 2002-03-06 | — | — | EP | disclosed |
| WO-2000075105-A1 | VALENCY PLATFORM MOLECULES COMPRISING AMINOOXY GROUPS | LA JOLLA PHARMACEUTICAL COMPANY (US) | 2000-12-14 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230133656-A1 | HYDROGEL COMPOSITIONS AND USES THEREOF | CD44, UACA, ALDH1A2 | ALDH1A1 160/4885EPHX2 57/4885TSHR 2075/4885 |
| US-20070191263-A1 | Valency platform molecules comprising aminooxy groups | DAO, PAM, BCAT2 | ALDH1A1 2138/4885EPHX2 1315/4885TSHR 4451/4885 |
| US-20060141597-A1 | A conjugate of biologically active molecules e.g peptides, proteins, nucleic acids, hormones, lipids, antibodies, saccharides, epitopes, enzymes, drugs etc. and a polyoxyethylene containing aminoxy groups | SHBG, DAO, DNPEP | ALDH1A1 2934/4885EPHX2 903/4885TSHR 621/4885 |
| US-20250108048-A1 | STING AGONIST COMPOUNDS AND CONJUGATES | STING1, CGAS, MAVS | ALDH1A1 4814/4885EPHX2 2364/4885TSHR 2275/4885 |
| US-20040224366-A1 | Valency platform molecules comprising aminooxy groups | DAO, PAM, BCAT2 | ALDH1A1 2138/4885EPHX2 1315/4885TSHR 4451/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.